Speech-Language Pathologists in Danville, KY Accepting Medicare

14 Speech-Language Pathologists found. Showing 1 - 14

Karen Wellman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 Ridge View Rd, Danville, KY 40422 Phone: 314-963-3270

Boyle County Board Of Education Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 352 N Danville Byp, Danville, KY 40422 Phone: 859-236-6634

Mrs. Anna Marie Greene Diggs, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 409 Stewarts Ln N, Danville, KY 40422 Phone: 859-236-0878    Fax: 859-236-0878

Ms. Megan Rae Wesley Lopez, M.A.ED./CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 329 Brookside Dr, Danville, KY 40422 Phone: 859-358-8424

Amanda Back, MS SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Daniel Dr, Danville, KY 40422 Phone: 859-239-6670

Toni Morrow Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 642 N 3rd St, Danville, KY 40422 Phone: 859-236-3972

Cheryl Faul, MS SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Daniel Dr, Danville, KY 40422 Phone: 859-239-6670

Nikki Wright, MS SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Daniel Dr, Danville, KY 40422 Phone: 859-239-6670

Laura Mize Group Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 224 Jane Trl, Danville, KY 40422 Phone: 502-232-0400

Mrs. Rachel Elizabeth Key, M.S. SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 409 Stewarts Ln N, Danville, KY 40422 Phone: 859-236-0878    Fax: 859-236-3570

Rebecca Marie Simpson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 426 E Main St, Danville, KY 40422 Phone: 513-515-7530

Karen Totsuka Iii Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 642 Nth 3rd St, Danville, KY 40422 Phone: 859-236-3972

Ms. Sara Ann R. Derringer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 585 Goggin Ln, Danville, KY 40422 Phone: 859-236-0083

Mrs. Laura Danielle Buis, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 108 Silvercreek Dr, Danville, KY 40422 Phone: 606-706-6219

News Archive

Philips introduces new ultrasound digital health device for point-of-care diagnostics in the UK

Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.

Australian, U.S. Department of VA to collaborate on new military deployment research project

The U.S. Department of Veterans Affairs will collaborate with the Australian Department of Veterans Affairs on a new research effort focused on investigating the impact of recent conflicts on the health of returning Servicemembers.

Disparities in limb salvage procedures may be driven by SES, access to high-volume hospitals

Researchers from Brigham and Women's Hospital at Harvard Medical School in Boston, MA have published a study in the February Journal of Vascular Surgery stating that disparities in limb salvage procedures may be driven by socioeconomic status and access to high-volume hospitals.

Canopus BioPharma enters phase II clinical trials with CB1400

Canopus BioPharma, Inc. has announced that the South African Medicines Control Council has granted approval for a Phase II study in 30 cancer patients evaluating the protective effect of CB1400 on the gastrointestional tract from radiation-induced mucositis. This new trial is an important step forward in the development of CB1400 as a novel, preventative, anti-mucositis agent.

Read more Medical News

› Verified 5 days ago